tegafur has been researched along with Primary Peritonitis in 25 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 59-year-old man diagnosed as gastric cancer with peritonitis carcinomatosa was treated with paclitaxel and TS-1; 60 mg/m(2)/day of paclitaxel was given on days 1 and 8, and 60-80 mg/m(2)/day of TS-1 was given for 2 weeks." | 7.75 | Advanced gastric cancer patient with peritonitis carcinomatosa successfully treated with a combination therapy of paclitaxel and TS-1, but relapsed with multiple bone metastasis and died from rapidly progressive meningitis carcinomatosa--advanced gastric ( Hasegawa, K; Hirono, H; Shibasaki, K; Soga, K; Watanabe, T; Yoneoka, Y, 2009) |
| "We report two cases of advanced gastric cancer." | 5.38 | [Two cases of advanced gastric cancer with peritonitis carcinomatosa that showed disappearance of ascites and obtained a good quality of life by using DIF and paclitaxel]. ( Kodama, M; Mekata, E; Okumura, K; Shiogai, Y; Tan, T; Tani, S, 2012) |
| "Goblet cell carcinoid of the appendix is a rare neoplasm and clinically tends to take a malignant course." | 5.35 | [A case of peritonitis carcinomatosa from goblet cell carcinoid of the appendix treated by intraperitoneal paclitaxel and systemic S-1 chemotherapy]. ( Fujimoto, H; Harada, E; Horiuchi, N; Iwasaka, N; Kashima, M; Kimura, S; Masuda, K; Matsushita, T; Nakamura, S; Oshima, Y; Shichijo, K; Shinomiya, S; Takeichi, T; Tamaki, Y; Yoshida, S, 2008) |
| "We diagnosed her case to be bilateral breast cancer with peritonitis carcinomatosa, lymph node metastases and bony metastases." | 5.35 | [A case of bilateral breast cancer and metastatic gastric cancer with peritonitis carcinomatosa successfully treated with a combination therapy of S-1 and paclitaxel]. ( Aramaki, N; Iizuka, M; Kuranami, M; Kurita, A; Miyauchi, K; Nakakuma, T; Sengoku, N; Shiozawa, K; Ueno, S, 2009) |
| "After the 5th course, the stenosis of colon and ascites had disappeared in a barium enema and CT scan, respectively." | 5.32 | [A case of advanced type 4 gastric cancer with peritonitis dissemination, navel metastasis effectively treated with combined chemotherapy of biweekly paclitaxel (TXL) and TS-1]. ( Aikou, T; Arima, H; Hamada, N; Hokita, S; Ishigami, S; Maeda, S; Miyazono, F; Natsugoe, S; Takao, S; Takatori, H, 2003) |
| "A 59-year-old man diagnosed as gastric cancer with peritonitis carcinomatosa was treated with paclitaxel and TS-1; 60 mg/m(2)/day of paclitaxel was given on days 1 and 8, and 60-80 mg/m(2)/day of TS-1 was given for 2 weeks." | 3.75 | Advanced gastric cancer patient with peritonitis carcinomatosa successfully treated with a combination therapy of paclitaxel and TS-1, but relapsed with multiple bone metastasis and died from rapidly progressive meningitis carcinomatosa--advanced gastric ( Hasegawa, K; Hirono, H; Shibasaki, K; Soga, K; Watanabe, T; Yoneoka, Y, 2009) |
| "However, recurrence occurred and the patient achieved complete response following tegafur/gimeracil/oteracil-based chemotherapy." | 2.55 | Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature. ( Ikeyama, M; Ishizone, S; Nakayama, J; Yoshizawa, J, 2017) |
| "We report two cases of advanced gastric cancer." | 1.38 | [Two cases of advanced gastric cancer with peritonitis carcinomatosa that showed disappearance of ascites and obtained a good quality of life by using DIF and paclitaxel]. ( Kodama, M; Mekata, E; Okumura, K; Shiogai, Y; Tan, T; Tani, S, 2012) |
| "We report two cases of advanced gastric cancer successfully treated with combination S-1 and docetaxel (DOC) therapy." | 1.36 | [Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel]. ( Hasegawa, H; Kijima, T; Kitahara, M; Kubo, H; Miyahara, M; Tada, K, 2010) |
| "Goblet cell carcinoid of the appendix is a rare neoplasm and clinically tends to take a malignant course." | 1.35 | [A case of peritonitis carcinomatosa from goblet cell carcinoid of the appendix treated by intraperitoneal paclitaxel and systemic S-1 chemotherapy]. ( Fujimoto, H; Harada, E; Horiuchi, N; Iwasaka, N; Kashima, M; Kimura, S; Masuda, K; Matsushita, T; Nakamura, S; Oshima, Y; Shichijo, K; Shinomiya, S; Takeichi, T; Tamaki, Y; Yoshida, S, 2008) |
| "The patient was diagnosed with typeIII gastric cancer by gastroendoscopy postoperatively." | 1.35 | [A case of perforated gastric cancer in which resection for elimination was possible S-1/CDDP combined chemotherapy for peritonitis carcinomatosa]. ( Itakura, T; Sugimoto, T; Uesaka, K, 2009) |
| "Two unresectable advanced gastric cancer cases with peritoneal metastases were successfully treated by the combination therapy of S-1 and paclitaxel." | 1.35 | [Two advanced gastric cancer cases with peritoneal metastases successfully treated by s-1/paclitaxel combination therapy]. ( Ando, T; Furuta, R; Goto, H; Ina, K; Kataoka, T; Kayukawa, S; Masaki, A; Nagao, S; Nishio, T, 2009) |
| "The prognosis for advanced pancreatic cancer with peritoneal dissemination is extremely poor, and no effective standard therapy has been established." | 1.35 | [Continuous treatment with S-1, an effective strategy for an older adult with unresectable advanced pancreatic cancer with peritoneal dissemination-a case report]. ( Inaba, K; Konno, H; Okamoto, N, 2009) |
| "We diagnosed her case to be bilateral breast cancer with peritonitis carcinomatosa, lymph node metastases and bony metastases." | 1.35 | [A case of bilateral breast cancer and metastatic gastric cancer with peritonitis carcinomatosa successfully treated with a combination therapy of S-1 and paclitaxel]. ( Aramaki, N; Iizuka, M; Kuranami, M; Kurita, A; Miyauchi, K; Nakakuma, T; Sengoku, N; Shiozawa, K; Ueno, S, 2009) |
| "After the 5th course, the stenosis of colon and ascites had disappeared in a barium enema and CT scan, respectively." | 1.32 | [A case of advanced type 4 gastric cancer with peritonitis dissemination, navel metastasis effectively treated with combined chemotherapy of biweekly paclitaxel (TXL) and TS-1]. ( Aikou, T; Arima, H; Hamada, N; Hokita, S; Ishigami, S; Maeda, S; Miyazono, F; Natsugoe, S; Takao, S; Takatori, H, 2003) |
| "Treatment of advanced gastric cancers with peritonitis carcinomatosa is very difficult, because none of the various therapies (operation, chemotherapy, hyperthermia etc." | 1.32 | [A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites]. ( Doi, K; Horiuchi, T; Nakamura, T; Okubo, Y; Shimada, K; Tanabe, S; Tanaka, K; Tanaka, S; Uchinami, M; Yoshida, M, 2004) |
| "Although the prognosis of recurrent gastric cancer with peritoneal dissemination was extremely poor, this case might suggest a possibility that intensive therapies are useful in maintaining the quality of life and improving survival." | 1.32 | [A case of recurrent gastric cancer with peritoneal dissemination successfully treated with DJ stents against bilateral hydronephrosis and chemotherapy]. ( Ebisui, C; Fujimoto, T; Fukuchi, N; Hasuike, Y; Hayashi, N; Izawa, H; Sakita, I; Souma, I; Yoshida, T, 2004) |
| "One of the breast cancer patients introduced here suffered from recurrent carcinomatous pleurisy and the other from recurrent carcinomatous peritonitis." | 1.31 | [Improved QOL with cancer chemotherapy in two patients with breast cancer suffering form carcinomatous pleurisy and carcinomatous peritonitis]. ( Fujitomi, Y; Fujiyoshi, K; Yasue, K, 2000) |
| "Because the subjects studied were gastric cancer cases exceeding H2, the present investigation resulted in the increase of metastatic liver lesions, a problem to be studied in future." | 1.28 | [CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis]. ( Hasegawa, Y; Honnma, S; Nakashima, Y; Takanashi, K; Yajima, K, 1991) |
| "The cases were comprised of 9 gastric cancers, 6 colorectal cancers, 1 appendiceal carcinoma, and 1 malignant tumor of retroperitoneum, all of which were observed to have peritoneal dissemination during surgical operations." | 1.28 | [Evaluation of intraperitoneal cancer chemotherapy using an implantable reservoir in patients with peritonitis carcinomatosa]. ( Katsuki, Y; Nishimura, A; Tsuji, Y; Yasuda, T, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 14 (56.00) | 29.6817 |
| 2010's | 5 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshizawa, J | 1 |
| Ishizone, S | 1 |
| Ikeyama, M | 1 |
| Nakayama, J | 1 |
| Katayama, K | 1 |
| Nishino, T | 1 |
| Takahashi, Y | 1 |
| Tanaka, T | 1 |
| Okitsu, H | 1 |
| Okitsu, N | 1 |
| Neduka, H | 1 |
| Munemoto, M | 1 |
| Ojima, T | 1 |
| Earashi, M | 1 |
| Fujii, H | 1 |
| Nonomura, A | 1 |
| Nakamura, S | 1 |
| Kimura, S | 1 |
| Kashima, M | 1 |
| Shichijo, K | 1 |
| Yoshida, S | 1 |
| Harada, E | 1 |
| Matsushita, T | 1 |
| Oshima, Y | 1 |
| Tamaki, Y | 1 |
| Horiuchi, N | 1 |
| Takeichi, T | 1 |
| Fujimoto, H | 1 |
| Masuda, K | 1 |
| Iwasaka, N | 1 |
| Shinomiya, S | 1 |
| Sugimoto, T | 1 |
| Itakura, T | 1 |
| Uesaka, K | 1 |
| Watanabe, T | 1 |
| Hirono, H | 1 |
| Hasegawa, K | 1 |
| Soga, K | 1 |
| Shibasaki, K | 1 |
| Yoneoka, Y | 1 |
| Ina, K | 1 |
| Furuta, R | 1 |
| Kataoka, T | 1 |
| Nishio, T | 1 |
| Nagao, S | 1 |
| Kayukawa, S | 1 |
| Masaki, A | 1 |
| Ando, T | 1 |
| Goto, H | 1 |
| Okamoto, N | 1 |
| Inaba, K | 1 |
| Konno, H | 1 |
| Ueno, S | 1 |
| Nakakuma, T | 1 |
| Aramaki, N | 1 |
| Shiozawa, K | 1 |
| Iizuka, M | 1 |
| Kurita, A | 1 |
| Miyauchi, K | 1 |
| Sengoku, N | 1 |
| Kuranami, M | 1 |
| Kubo, H | 1 |
| Kijima, T | 1 |
| Kitahara, M | 1 |
| Tada, K | 1 |
| Miyahara, M | 1 |
| Hasegawa, H | 1 |
| Okumura, K | 1 |
| Tani, S | 1 |
| Shiogai, Y | 1 |
| Kodama, M | 1 |
| Mekata, E | 1 |
| Tan, T | 1 |
| Hatanaka, F | 1 |
| Matsuo, S | 1 |
| Aratake, Y | 1 |
| Uchimura, K | 1 |
| Yokota, M | 1 |
| Sumii, T | 1 |
| Iguchi, H | 1 |
| Funakoshi, A | 1 |
| Hokita, S | 1 |
| Takatori, H | 1 |
| Ishigami, S | 1 |
| Miyazono, F | 1 |
| Maeda, S | 1 |
| Arima, H | 1 |
| Natsugoe, S | 1 |
| Takao, S | 1 |
| Aikou, T | 1 |
| Hamada, N | 1 |
| Nakagawa, A | 1 |
| Ichiki, M | 1 |
| Sai, K | 1 |
| Sugawara, H | 1 |
| Nakamura, T | 1 |
| Shimada, K | 1 |
| Okubo, Y | 1 |
| Tanaka, S | 1 |
| Tanabe, S | 2 |
| Yoshida, M | 1 |
| Doi, K | 1 |
| Uchinami, M | 1 |
| Horiuchi, T | 1 |
| Tanaka, K | 1 |
| Ebisui, C | 1 |
| Souma, I | 1 |
| Hayashi, N | 1 |
| Fukuchi, N | 1 |
| Izawa, H | 1 |
| Yoshida, T | 1 |
| Sakita, I | 1 |
| Hasuike, Y | 1 |
| Fujimoto, T | 1 |
| Shibata, N | 1 |
| Eto, TA | 1 |
| Hotokezaka, M | 1 |
| Iwamura, T | 1 |
| Chijiiwa, K | 1 |
| Ohta, H | 1 |
| Doi, T | 1 |
| Kikuchi, S | 1 |
| Sato, Y | 1 |
| Okuda, T | 1 |
| Fujimi, A | 1 |
| Kanisawa, Y | 1 |
| Izumi, K | 1 |
| Kitahara, T | 1 |
| Kurokawa, T | 1 |
| Iwasa, H | 1 |
| Mimura, K | 1 |
| Terashima, H | 1 |
| Hiraide, H | 1 |
| Mizoguchi, O | 1 |
| Kanabe, S | 1 |
| Tamaki, K | 1 |
| Kadota, T | 1 |
| Hatsuse, K | 1 |
| Takayanagi, N | 1 |
| Danjo, Y | 1 |
| Fujitomi, Y | 1 |
| Fujiyoshi, K | 1 |
| Yasue, K | 1 |
| Hasegawa, Y | 1 |
| Honnma, S | 1 |
| Takanashi, K | 1 |
| Yajima, K | 1 |
| Nakashima, Y | 1 |
| Tsuji, Y | 1 |
| Nishimura, A | 1 |
| Katsuki, Y | 1 |
| Yasuda, T | 1 |
| Seki, H | 1 |
| Takahashi, H | 1 |
| Kimura, K | 1 |
| Ishibashi, H | 1 |
| Hirakawa, K | 1 |
| Nakajima, H | 1 |
| Ioka, J | 1 |
| Shirono, K | 1 |
| Ochiai, K | 1 |
| Tomita, K | 1 |
| Kitagawa, Y | 1 |
1 review available for tegafur and Primary Peritonitis
| Article | Year |
|---|---|
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Topics: Adenocarcinoma; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Drug Combination | 2017 |
24 other studies available for tegafur and Primary Peritonitis
| Article | Year |
|---|---|
[Approximately four years of survival benefits for a case of gastric cancer postoperative carcinomatous peritonitis by combined modality therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Combined Modality Therapy; | 2013 |
[Highly Advanced Gastric Cancer Leading to Immediate Perforation on Day Three of Chemotherapy with S-1 plus Oxaliplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Organoplati | 2016 |
[A case of peritonitis carcinomatosa from goblet cell carcinoid of the appendix treated by intraperitoneal paclitaxel and systemic S-1 chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Colonic Neoplasms; Colonoscop | 2008 |
[A case of perforated gastric cancer in which resection for elimination was possible S-1/CDDP combined chemotherapy for peritonitis carcinomatosa].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastroscopy; Hum | 2009 |
Advanced gastric cancer patient with peritonitis carcinomatosa successfully treated with a combination therapy of paclitaxel and TS-1, but relapsed with multiple bone metastasis and died from rapidly progressive meningitis carcinomatosa--advanced gastric
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Drug Combinations; F | 2009 |
[Two advanced gastric cancer cases with peritoneal metastases successfully treated by s-1/paclitaxel combination therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2009 |
[Continuous treatment with S-1, an effective strategy for an older adult with unresectable advanced pancreatic cancer with peritoneal dissemination-a case report].
Topics: Adenocarcinoma; Administration, Oral; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combi | 2009 |
[A case of bilateral breast cancer and metastatic gastric cancer with peritonitis carcinomatosa successfully treated with a combination therapy of S-1 and paclitaxel].
Topics: Adenocarcinoma, Scirrhous; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antin | 2009 |
[Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2010 |
[Two cases of advanced gastric cancer with peritonitis carcinomatosa that showed disappearance of ascites and obtained a good quality of life by using DIF and paclitaxel].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Dihydrouracil Dehydrogenase (NADP); D | 2012 |
[A case of recurrent early gastric cancer with peritonitis carcinomatosa successfully treated with TS-1].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Ascites; Drug Administration Schedule; Drug Combina | 2003 |
[A case of advanced type 4 gastric cancer with peritonitis dissemination, navel metastasis effectively treated with combined chemotherapy of biweekly paclitaxel (TXL) and TS-1].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colonic Di | 2003 |
[Efficacy of TS-1 in patients with peritonitis carcinomatosa from gastric cancer].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Administration Schedul | 2003 |
[A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin; Drug Administrati | 2004 |
[A case of recurrent gastric cancer with peritoneal dissemination successfully treated with DJ stents against bilateral hydronephrosis and chemotherapy].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Combined M | 2004 |
[An unresectable advanced gastric cancer with Virchow's metastasis, carcinomatous ascites and rectal stenosis, effectively managed with combined chemotherapy of biweekly paclitaxel and TS-1].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined C | 2005 |
[A case of unresectable advanced pancreatic cancer with peritoneal dissemination responding to continuous dose S-1 monotherapy after chemo-radiation therapy].
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Deoxycytidine; Drug Combinations; Female | 2007 |
[Intraperitoneal administration of FT-207 for mouse peritonitis carcinomatosa].
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Division; Fluorouracil; Injections, Intraperitoneal; Macroph | 1984 |
[A case of gastric cancer with peritonitis carcinomatosa and malignant biliary stenosis treated by intraperitoneal CDDP and MMC with UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract | 1998 |
[Improved QOL with cancer chemotherapy in two patients with breast cancer suffering form carcinomatous pleurisy and carcinomatous peritonitis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubic | 2000 |
[CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; | 1991 |
[Evaluation of intraperitoneal cancer chemotherapy using an implantable reservoir in patients with peritonitis carcinomatosa].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Cisplatin; Colorectal Ne | 1990 |
[Concentration of 5-FU and tegafur in the ascites fluid in patients with peritonitis carcinomatosa after UFT oral administration].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Fluorouracil; G | 1987 |
[A case of gastric cancer with peritonitis carcinomatosa which improved upon oral administration of UFT, mitomycin C and lentinan].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; | 1987 |